Facial Contouring

Explainer · July 29, 2026 · 5 min · By Darius Engelhardt

Masseter Botulinum Toxin vs Buccal Fat Removal: Two Very Different Ways to Slim the Lower Face

Both procedures promise a narrower lower face, but they act on different tissues, carry different risks, and suit different anatomy. Here is how clinicians actually decide between them.

Masseter Botulinum Toxin vs Buccal Fat Removal: Two Very Different Ways to Slim the Lower Face

Ask for a slimmer lower face and you will likely hear about two procedures: botulinum toxin injections into the masseter muscle, and surgical removal of the buccal fat pad. They are often discussed as if they were interchangeable. They are not. They target entirely different structures, and choosing the wrong one for your anatomy can mean spending money on a result that never appears, or worse, a change you cannot undo.

What each procedure actually does

The masseter is one of the primary chewing muscles. It runs from the cheekbone down to the angle of the jaw, and in some people it is genuinely enlarged, a condition called masseter hypertrophy. This can result from genetics, chronic teeth grinding, gum chewing, or clenching. When botulinum toxin is injected into the masseter, it blocks the release of acetylcholine at the neuromuscular junction. The muscle receives fewer signals to contract, and over 4 to 12 weeks it gradually shrinks through disuse atrophy. The jaw angle softens and the lower face narrows. The effect is temporary, typically lasting 4 to 6 months per treatment, though repeated sessions can produce longer-lasting reduction.

Buccal fat removal targets something else entirely: a deep, encapsulated fat pad that sits in the mid-cheek, between the buccinator and masseter muscles. Through a small incision inside the mouth, a surgeon removes a portion of this pad. The result is a hollowing beneath the cheekbone, the look often described as more sculpted or chiseled. Unlike subcutaneous fat, the buccal pad does not fluctuate much with weight, and once removed, it does not grow back. The procedure is permanent.

How clinicians decide which structure is the problem

A competent assessment starts with palpation. A practitioner asks the patient to clench the jaw. If the width of the lower face visibly increases and a firm, bulging muscle can be felt at the jaw angle, the masseter is a major contributor, and toxin is the logical tool. If the fullness sits higher, in the mid-cheek, feels soft, and does not change with clenching, the buccal pad or general facial fat is more likely responsible.

Many patients have some of both. Some have neither: in patients whose lower face fullness comes from subcutaneous fat, jowling, or skin laxity, neither procedure will deliver what they expect. This is a common source of disappointment, especially with buccal fat removal performed on faces that were never fat-heavy in that compartment to begin with.

The aging question, and why it matters most for buccal fat

The most serious clinical debate around buccal fat removal concerns time. Facial fat compartments naturally deflate with age, particularly in the midface. A face that looks pleasingly sculpted at 25 after buccal fat removal may look gaunt or prematurely aged at 45, because the surgeon removed volume the face would eventually need. Many facial surgeons now decline the procedure in patients with naturally lean faces, or remove conservatively, precisely for this reason. There is no reliable way to restore the buccal pad once it is gone. Fat grafting and fillers can approximate volume, but not the original anatomy.

Masseter toxin does not carry this concern in the same way. Because the effect fades, an unsatisfying result resolves on its own. That said, it has its own risk profile: injecting too superficially or too anteriorly can weaken the risorius or zygomaticus muscles and cause an asymmetric smile. Over-treatment can reduce chewing strength, and a small number of patients report jaw fatigue with tough foods for several weeks. With very high doses or long-term repeated treatment, some clinicians report subtle sagging over the jaw angle in older patients with lax skin, because the shrunken muscle no longer supports the overlying tissue as fully.

Cost, downtime, and reversibility compared

Masseter toxin is an office procedure taking minutes, with no downtime beyond possible mild soreness. Results build gradually and require maintenance, so the cost is recurring. Buccal fat removal is a one-time surgical cost, performed under local anesthesia with or without sedation, with roughly one to two weeks of swelling and a soft diet during initial healing. Because incisions are intraoral, infection precautions matter, and rare complications include injury to the parotid duct or branches of the facial nerve, both of which run near the surgical field.

The bottom line

If the width you dislike bulges when you clench, think muscle, and toxin is the reversible, lower-risk starting point. If the fullness is a soft pad in the mid-cheek that has been there since adolescence regardless of weight, buccal fat removal may be the relevant procedure, but it deserves genuine caution given its permanence and the natural volume loss of aging. And if a practitioner recommends either procedure without asking you to clench your jaw, without palpating your cheek, or without discussing how your face may change over the next twenty years, that is a signal to seek a second opinion. The right procedure depends on which tissue is responsible, and that is an anatomical question, not a marketing one.

Related reading: Masseter Reduction vs Buccal Fat Removal: Two Very Different Ways to Slim the Lower Face.

More in Explainer

View all →